FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4246021919> ?p ?o ?g. }

• W4246021919 abstract "Background Terlipressin may reverse some of the circulatory changes associated with hepatorenal syndrome. Objectives To assess the beneficial and harmful effects of terlipressin for hepatorenal syndrome. Search methods Electronic searches in The Cochrane Hepato‐Biliary Group Controlled Trials Register, The Cochrane Renal Group Register, the Cochrane Central Register of Controlled Trials in The Cochrane Library, MEDLINE, and EMBASE were combined with scanning of bibliographies and conference proceedings, and correspondence with experts and pharmaceutical companies. Last search update was July 2006. Selection criteria Randomised clinical trials were included irrespective of dose or treatment duration. Included patients had type 1 or type 2 hepatorenal syndrome. Co‐interventions were allowed if administered equally to both treatment and control groups. Data collection and analysis Data were retrieved from trial reports and correspondence with the authors of included trials. Mortality was the primary outcome. Meta‐analyses were performed to calculate risk differences (RD) for binary outcomes and weighted mean differences (WMD) for continuous outcomes. Both were presented with 95% confidence intervals (CI). Due to the limited number of trials, no subgroup analyses were performed. Main results The initial searches identified 645 potentially relevant references. Six randomised trials were eligible for inclusion. Three trials are still ongoing. Three trials with a total of 51 patients assessed terlipressin 1 mg bid for 2 to 15 days. Co‐interventions included albumin, fresh frozen plasma, and cimetidine 800 mg daily. One trial reported adequate bias control assessed by randomisation and blinding. All trials reported mortality. Terlipressin reduced mortality rates by 34% (RD ‐0.34, 95% CI ‐0.56 to ‐0.12). The control group mortality rate was 65%. Terlipressin improved renal function assessed by creatinine clearance (WMD 21 ml/min, 95% CI 17 to 26), serum creatinine (WMD ‐219 micromol/l, 95% CI ‐244 to ‐194), and urine output (WMD 707 ml/day, 95% CI ‐212 to 1625). Adverse events included headache, abdominal pain, cardiac arrhythmia, and hypertension. Authors' conclusions Additional evidence on terlipressin for hepatorenal syndrome is needed before reliable treatment recommendations can be made. The dose and duration of therapy, and the influence of co‐interventions remain to be established." @default.
• W4246021919 created "2022-05-12" @default.
• W4246021919 creator A5014786282 @default.
• W4246021919 creator A5045441786 @default.
• W4246021919 creator A5075627655 @default.
• W4246021919 date "2006-10-18" @default.
• W4246021919 modified "2023-09-29" @default.
• W4246021919 title "Terlipressin for hepatorenal syndrome" @default.
• W4246021919 cites W141198166 @default.
• W4246021919 cites W1525507841 @default.
• W4246021919 cites W1964489041 @default.
• W4246021919 cites W1971969855 @default.
• W4246021919 cites W1972241537 @default.
• W4246021919 cites W2011199481 @default.
• W4246021919 cites W2018940564 @default.
• W4246021919 cites W2027107786 @default.
• W4246021919 cites W2029276570 @default.
• W4246021919 cites W2033110222 @default.
• W4246021919 cites W2034715145 @default.
• W4246021919 cites W2034719174 @default.
• W4246021919 cites W2036943696 @default.
• W4246021919 cites W2038261793 @default.
• W4246021919 cites W2061489021 @default.
• W4246021919 cites W2062775021 @default.
• W4246021919 cites W2072646675 @default.
• W4246021919 cites W2074466817 @default.
• W4246021919 cites W2075974527 @default.
• W4246021919 cites W2078113157 @default.
• W4246021919 cites W2079304328 @default.
• W4246021919 cites W2087450723 @default.
• W4246021919 cites W2090325310 @default.
• W4246021919 cites W2098005391 @default.
• W4246021919 cites W2103472550 @default.
• W4246021919 cites W2108128920 @default.
• W4246021919 cites W2115229983 @default.
• W4246021919 cites W2117294447 @default.
• W4246021919 cites W2120179295 @default.
• W4246021919 cites W2127765911 @default.
• W4246021919 cites W2131903288 @default.
• W4246021919 cites W2132058135 @default.
• W4246021919 cites W2134005739 @default.
• W4246021919 cites W2136390689 @default.
• W4246021919 cites W2168352227 @default.
• W4246021919 cites W2214600008 @default.
• W4246021919 cites W2316957914 @default.
• W4246021919 cites W4237367369 @default.
• W4246021919 cites W4255387568 @default.
• W4246021919 doi "https://doi.org/10.1002/14651858.cd005162.pub2" @default.
• W4246021919 hasPublicationYear "2006" @default.
• W4246021919 type Work @default.
• W4246021919 citedByCount "13" @default.
• W4246021919 countsByYear W42460219192012 @default.
• W4246021919 countsByYear W42460219192014 @default.
• W4246021919 countsByYear W42460219192017 @default.
• W4246021919 countsByYear W42460219192019 @default.
• W4246021919 crossrefType "reference-entry" @default.
• W4246021919 hasAuthorship W4246021919A5014786282 @default.
• W4246021919 hasAuthorship W4246021919A5045441786 @default.
• W4246021919 hasAuthorship W4246021919A5075627655 @default.
• W4246021919 hasConcept C126322002 @default.
• W4246021919 hasConcept C142724271 @default.
• W4246021919 hasConcept C168563851 @default.
• W4246021919 hasConcept C177713679 @default.
• W4246021919 hasConcept C204787440 @default.
• W4246021919 hasConcept C27081682 @default.
• W4246021919 hasConcept C2776478404 @default.
• W4246021919 hasConcept C2776988256 @default.
• W4246021919 hasConcept C2777214474 @default.
• W4246021919 hasConcept C2779393834 @default.
• W4246021919 hasConcept C44249647 @default.
• W4246021919 hasConcept C535046627 @default.
• W4246021919 hasConcept C71924100 @default.
• W4246021919 hasConcept C95190672 @default.
• W4246021919 hasConceptScore W4246021919C126322002 @default.
• W4246021919 hasConceptScore W4246021919C142724271 @default.
• W4246021919 hasConceptScore W4246021919C168563851 @default.
• W4246021919 hasConceptScore W4246021919C177713679 @default.
• W4246021919 hasConceptScore W4246021919C204787440 @default.
• W4246021919 hasConceptScore W4246021919C27081682 @default.
• W4246021919 hasConceptScore W4246021919C2776478404 @default.
• W4246021919 hasConceptScore W4246021919C2776988256 @default.
• W4246021919 hasConceptScore W4246021919C2777214474 @default.
• W4246021919 hasConceptScore W4246021919C2779393834 @default.
• W4246021919 hasConceptScore W4246021919C44249647 @default.
• W4246021919 hasConceptScore W4246021919C535046627 @default.
• W4246021919 hasConceptScore W4246021919C71924100 @default.
• W4246021919 hasConceptScore W4246021919C95190672 @default.
• W4246021919 hasLocation W42460219191 @default.
• W4246021919 hasOpenAccess W4246021919 @default.
• W4246021919 hasPrimaryLocation W42460219191 @default.
• W4246021919 hasRelatedWork W2014943083 @default.
• W4246021919 hasRelatedWork W2374685850 @default.
• W4246021919 hasRelatedWork W2381982637 @default.
• W4246021919 hasRelatedWork W2531052508 @default.
• W4246021919 hasRelatedWork W2914141471 @default.
• W4246021919 hasRelatedWork W3013041320 @default.
• W4246021919 hasRelatedWork W3096683796 @default.
• W4246021919 hasRelatedWork W3132173363 @default.
• W4246021919 hasRelatedWork W4292248146 @default.
• W4246021919 hasRelatedWork W4385751578 @default.

• next